Company News
Glenmark Takes Direct U.S. Control of RYALTRIS®
Glenmark Pharmaceuticals assumes end-to-end commercialization and distribution of RYALTRIS® in the U.S. effective April 1, 2026.
RYALTRIS® is Glenmark's first innovative product in the U.S., a fixed-d
